NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
192 hedge funds and large institutions have $2.7B invested in NEVRO CORP. in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 70 increasing their positions, 66 reducing their positions, and 26 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 66
5% less capital invested
Capital invested by funds: $2.83B → $2.7B (-$130M)
8% less call options, than puts
Call options by funds: $12.8M | Put options by funds: $14M
3% less funds holding
Funds holding: 197 → 192 (-5)
12% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$78.2M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$45.1M |
| 3 |
Jennison Associates
New York
|
+$25.5M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$22.4M |
| 5 |
BlackRock
New York
|
+$22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$50.7M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$33.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$29.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29.4M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$17.2M |
NVRO Hedge Fund Activity: Q2 2018 in Review
192 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2018, worth a combined $2.7B — down 4.6% from $2.83B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of NVRO and 23 opened new positions — a net loss of 3 holders — while 66 trimmed existing stakes and 70 added.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $78.2M. The largest seller was Millennium Management, exiting entirely with an estimated $50.7M sold.
- 192 institutional investors held NEVRO CORP. (NVRO) as of Q2 2018, down from 197 in Q1 2018.
- Funds reported $2.7B of NEVRO CORP. stock for Q2 2018, down 4.6% quarter-over-quarter.
- 23 funds opened new NEVRO CORP. positions in Q2 2018 and 26 closed out, a net change of -3 holders.
- The largest NEVRO CORP. buyer in Q2 2018 was Consonance Capital Management, an estimated $78.2M added.
- The largest NEVRO CORP. seller in Q2 2018 was Millennium Management, an estimated $50.7M sold.
Based on aggregated 13F filings for Q2 2018.